Literature DB >> 4548355

In vivo and in vitro effects of tumour specific antibodies with chlorambucil.

D A Davies, G J O'Neill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4548355      PMCID： PMC2149081     

Source DB:  PubMed          Journal:  Br J Cancer Suppl        ISSN： 0306-9443


× No keyword cloud information.
  9 in total

1.  Passive immunity in mice against C57BL leukosis E.L. 4 by means of iso-immune serum.

Authors:  P A GORER; D B AMOS
Journal:  Cancer Res       Date:  1956-05       Impact factor: 12.701

2.  [Effect on mouse leukemia 1210 of a combination by diazo-reaction of amethopterin and gamma-globulins from hamsters inoculated with such leukemia by heterografts].

Authors:  G MATHE; L O C TRAN BA; J BERNARD
Journal:  C R Hebd Seances Acad Sci       Date:  1958-03-10

3.  Antibody as carrier of chlorambucil.

Authors:  T Ghose; S P Nigam
Journal:  Cancer       Date:  1972-05       Impact factor: 6.860

4.  Antitumor effects of antibody-diphtheria toxin conjugates: use of hapten-coated tumor cells as an antigenic target.

Authors:  F L Moolten; N J Capparell; S R Cooperband
Journal:  J Natl Cancer Inst       Date:  1972-10       Impact factor: 13.506

5.  Antigenic analysis of L strain cells: a new murine leukemia-associated antigen, "L".

Authors:  J C Leclerc; J P Levy; B Varet; S Oppenheim; A Senik
Journal:  Cancer Res       Date:  1970-07       Impact factor: 12.701

6.  Xenoantisera against lymphoid cells: specificity and use in monitoring purification of mouse and human histocompatibility antigens.

Authors:  N A Staines; G J O'Neill; K Guy; D A Davies
Journal:  Tissue Antigens       Date:  1973

7.  Selective destruction of target cells by diphtheria toxin conjugated to antibody directed against antigens on the cells.

Authors:  F L Moolten; S R Cooperband
Journal:  Science       Date:  1970-07-03       Impact factor: 47.728

8.  Inhibition by carbohydrates of the cytotoxicity of heterologous sera for mouse thymus cells.

Authors:  M Schlesinger; A Cohen; D Hurvitz
Journal:  Isr J Med Sci       Date:  1966 Sep-Oct

9.  Immunochemotherapy of cancer with chlorambucil-carrying antibody.

Authors:  T Ghose; S T Norvell; A Guclu; D Cameron; A Bodurtha; A S MacDonald
Journal:  Br Med J       Date:  1972-08-26
  9 in total
  13 in total

Review 1.  Antibodies as specific carriers for chemotherapeutic agents.

Authors:  F H Lee; K M Hwang
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

2.  In vitro cytotoxicity of anti-theta (Thy-1) antibodies combined with chlorambucil.

Authors:  G J O'Neill; B A Pearson; D A Davies
Journal:  Immunology       Date:  1975-02       Impact factor: 7.397

Review 3.  Antibody-targeted polymer-bound drugs.

Authors:  B Ríhová
Journal:  Folia Microbiol (Praha)       Date:  1995       Impact factor: 2.099

Review 4.  Antibody-mediated targeting in the treatment and diagnosis of cancer: an overview.

Authors:  C H Ford; A G Casson
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

5.  Inhibition of a mouse hepatoma by the alkylating agent Trenimon linked to immunoglobulins.

Authors:  T Ghose; A Guclu; R R Raman; A H Blair
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

6.  Cytotoxic effect of anti-idiotype antibody-chlorambucil conjugates against human lymphoblastoid cells.

Authors:  E Tung; J M Goust; W Y Chen; S S Kang; I Y Wang; A C Wang
Journal:  Immunology       Date:  1983-09       Impact factor: 7.397

7.  Cancer targeted therapeutics: From molecules to drug delivery vehicles.

Authors:  Daxing Liu; Debra T Auguste
Journal:  J Control Release       Date:  2015-09-02       Impact factor: 9.776

8.  Aggregation of chlorambucil in vitro may cause misinterpretation of protein binding data.

Authors:  D Blakeslee; M Chen; J C Kennedy
Journal:  Br J Cancer       Date:  1975-06       Impact factor: 7.640

9.  Localisation and toxicity study of a vindesine-anti-CEA conjugate in patients with advanced cancer.

Authors:  C H Ford; C E Newman; J R Johnson; C S Woodhouse; T A Reeder; G F Rowland; R G Simmonds
Journal:  Br J Cancer       Date:  1983-01       Impact factor: 7.640

10.  Protection of mice against syngeneic lymphomata: I. Use of antibodies.

Authors:  D A Davies; A J Manstone; S Buckham
Journal:  Br J Cancer       Date:  1974-10       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.